{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T10:01:19Z","timestamp":1783764079934,"version":"3.55.0"},"reference-count":34,"publisher":"The Journal of Rheumatology","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2012,8]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>Rheumatoid arthritis (RA) is a chronic inflammatory disease accompanied by many complications, and serious infections are associated with many of the advanced therapeutics used to treat it. We assessed serum procalcitonin (PCT) levels to distinguish bacterial infection from other complications in patients with RA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>One hundred eighteen patients experiencing an RA flare, noninfectious complication of RA or its treatment, nonbacterial infection, or bacterial infection were studied. Serum PCT concentrations were determined with a chemiluminescent enzyme immunoassay.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>All patients experiencing an RA flare showed negative PCT levels (\u2264 0.1 ng\/ml; n = 18). The PCT level was higher in the bacterial infection group (25.8% had levels \u2265 0.5 ng\/ml) than in the other 3 groups (0.0\u20134.3% had levels \u2265 0.5 ng\/ml) and the difference was significant among groups (p = 0.003). Conversely, no statistically significant difference was observed among the groups with C-reactive protein (CRP) concentration \u2265 0.3 mg\/dl (p = 0.513), white blood cell (WBC) count &gt; 8500\/mm<jats:sup>3<\/jats:sup> (p = 0.053), or erythrocyte sedimentation rate (ESR) &gt; 15 mm\/h (p = 0.328). The OR of high PCT level (\u2265 0.5 ng\/ml) for detection of bacterial infection was 19.13 (95% CI 2.44\u2013149.78, p = 0.005). Specificity and positive likelihood ratio of PCT \u2265 0.5 ng\/ml were highest (98.2% and 14.33, respectively) for detection of bacterial infection, although the sensitivity was low (25.8%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>Serum PCT level is a more specific marker for detection of bacterial infection than either CRP, ESR, or WBC count in patients with RA. High PCT levels (\u2265 0.5 ng\/ml) strongly suggest bacterial infection. However, PCT &lt; 0.5 ng\/ml, even if &lt; 0.2 ng\/ml, does not rule out bacterial infection and physicians should treat appropriately.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.111601","type":"journal-article","created":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T20:12:47Z","timestamp":1341173567000},"page":"1517-1523","source":"Crossref","is-referenced-by-count":31,"title":["Procalcitonin Is a Specific Marker for Detecting Bacterial Infection in Patients with Rheumatoid Arthritis"],"prefix":"10.3899","volume":"39","author":[{"given":"HIROE","family":"SATO","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NAOHITO","family":"TANABE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AKIRA","family":"MURASAWA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YASUHIRO","family":"OTAKI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TAKEHITO","family":"SAKAI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TOSHIAKI","family":"SUGAYA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SATOSHI","family":"ITO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIROSHI","family":"OTANI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ASAMI","family":"ABE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HAJIME","family":"ISHIKAWA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KIYOSHI","family":"NAKAZONO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TAKESHI","family":"KURODA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MASAAKI","family":"NAKANO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ICHIEI","family":"NARITA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2012,7,1]]},"reference":[{"key":"2018112909280740000_39.8.1517.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60784-3"},{"key":"2018112909280740000_39.8.1517.2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.126532"},{"key":"2018112909280740000_39.8.1517.3","doi-asserted-by":"publisher","DOI":"10.1007\/s001010050599"},{"key":"2018112909280740000_39.8.1517.4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021444"},{"key":"2018112909280740000_39.8.1517.5","doi-asserted-by":"publisher","DOI":"10.1210\/en.2003-0854"},{"key":"2018112909280740000_39.8.1517.6","first-page":"453","article-title":"Serum procalcitonin for discrimination between septic and non-septic arthritis","volume":"26","author":"Hugle","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"2018112909280740000_39.8.1517.7","doi-asserted-by":"publisher","DOI":"10.1080\/03009740310004135"},{"key":"2018112909280740000_39.8.1517.8","first-page":"303","article-title":"Diagnostic value of serum and synovial procalcitonin in acute arthritis: A prospective study of 42 patients","volume":"23","author":"Martinot","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"2018112909280740000_39.8.1517.9","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310302"},{"key":"2018112909280740000_39.8.1517.10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1949.02900430001001"},{"key":"2018112909280740000_39.8.1517.11","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-005-0388-9"},{"key":"2018112909280740000_39.8.1517.12","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199806000-00015"},{"key":"2018112909280740000_39.8.1517.13","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.4.337"},{"key":"2018112909280740000_39.8.1517.14","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199707)40:7<1250::AID-ART9>3.0.CO;2-A"},{"key":"2018112909280740000_39.8.1517.15","first-page":"1531","article-title":"Elevated procalcitonin levels in active Wegener\u2019s granulomatosis","volume":"25","author":"Moosig","year":"1998","journal-title":"J Rheumatol"},{"key":"2018112909280740000_39.8.1517.16","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm353"},{"key":"2018112909280740000_39.8.1517.17","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e3181772cca"},{"key":"2018112909280740000_39.8.1517.18","first-page":"123","article-title":"Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases","volume":"24","author":"Scire","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"2018112909280740000_39.8.1517.19","first-page":"114","article-title":"Diagnostic accuracy of serum procalcitonin concentrations for detecting systemic bacterial infection in patients with systemic autoimmune diseases","volume":"35","author":"Tamaki","year":"2008","journal-title":"J Rheumatol"},{"issue":"Suppl 6","key":"2018112909280740000_39.8.1517.20","first-page":"839","article-title":"Procalcitonin as an indicator of systemic response to infection in active pulmonary Wegener\u2019s granulomacytosis","volume":"59","author":"Zycinska","year":"2008","journal-title":"J Physiol Pharmacol"},{"key":"2018112909280740000_39.8.1517.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2009.10.004"},{"key":"2018112909280740000_39.8.1517.22","first-page":"2189","article-title":"Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still\u2019s disease","volume":"31","author":"Chen","year":"2004","journal-title":"J Rheumatol"},{"key":"2018112909280740000_39.8.1517.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2004.05.004"},{"key":"2018112909280740000_39.8.1517.24","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.01801.x"},{"key":"2018112909280740000_39.8.1517.25","doi-asserted-by":"publisher","DOI":"10.1016\/0272-6386(95)90157-4"},{"key":"2018112909280740000_39.8.1517.26","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100247"},{"key":"2018112909280740000_39.8.1517.27","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.153023"},{"key":"2018112909280740000_39.8.1517.28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4137\/BMI.S2300","article-title":"Changes in plasma IL-6, plasma VEGF and serum YKL-40 during treatment with etanercept and methotrexate or etanercept alone in patients with active rheumatoid arthritis despite methotrexate therapy","volume":"4","author":"Knudsen","year":"2009","journal-title":"Biomark Insights"},{"key":"2018112909280740000_39.8.1517.29","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15591-8"},{"key":"2018112909280740000_39.8.1517.30","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.1999.048"},{"key":"2018112909280740000_39.8.1517.31","doi-asserted-by":"publisher","DOI":"10.1097\/00006676-200310000-00008"},{"key":"2018112909280740000_39.8.1517.32","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-009-1185-0"},{"key":"2018112909280740000_39.8.1517.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.patbio.2005.10.001"},{"key":"2018112909280740000_39.8.1517.34","first-page":"358","article-title":"Semiquantitative determination of blood procalcitonin by the immunochromatographic BRAHMS PCT-Q test: False positive result","volume":"63","author":"Desvignes","year":"2005","journal-title":"Ann Biol Clin"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.111601","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T13:17:46Z","timestamp":1543497466000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.111601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,1]]},"references-count":34,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2012,8,1]]},"published-print":{"date-parts":[[2012,8]]}},"alternative-id":["10.3899\/jrheum.111601"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.111601","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,1]]}}}